SwePub
Sök i LIBRIS databas

  Extended search

L773:2673 6357
 

Search: L773:2673 6357 > Human Bone Marrow M...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Human Bone Marrow Mesenchymal Stromal Cell-Derived CXCL12, IL-6 and GDF-15 and Their Capacity to Support IgG-Secreting Cells in Culture Are Divergently Affected by Doxorubicin

Lasaviciute, Gintare, 1990- (author)
Stockholms universitet,Institutionen för molekylär biovetenskap, Wenner-Grens institut
Höbinger, Anna (author)
Ujvari, Dorina (author)
show more...
Salamon, Daniel (author)
Yusuf, Aisha (author)
Sundin, Mikael (author)
Sverremark-Ekström, Eva, 1968- (author)
Stockholms universitet,Institutionen för molekylär biovetenskap, Wenner-Grens institut
Chikhi, Rayan (author)
Nilsson, Anna (author)
Saghafian-Hedengren, Shanie (author)
show less...
 (creator_code:org_t)
2021-03-13
2021
English.
In: Hemato. - : MDPI AG. - 2673-6357. ; 2:1, s. 154-166
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Various subsets of bone marrow mesenchymal stromal cells (BM MSCs), including fibroblasts, endothelial, fat and reticular cells, are implicated in the regulation of the hematopoietic microenvironment and the survival of long-lived antibody-secreting cells (ASCs). Nowadays it is widely acknowledged that vaccine-induced protective antibody levels are diminished in adults and children that are treated for hematological cancers. A reason behind this could be damage to the BM MSC niche leading to a diminished pool of ASCs. To this end, we asked whether cell cytotoxic treatment alters the capacity of human BM MSCs to support the survival of ASCs. To investigate how chemotherapy affects soluble factors related to the ASC niche, we profiled a large number of cytokines and chemokines from in vitro-expanded MSCs from healthy donors or children who were undergoing therapy for acute lymphoblastic leukemia (ALL), following exposure to a widely used anthracycline called doxorubicin (Doxo). In addition, we asked if the observed changes in the measured soluble factors after Doxo exposure impacted the ability of the BM niche to support humoral immunity by co-culturing Doxo-exposed BM MSCs with in vitro-differentiated ASCs from healthy blood donors, and selective neutralization of cytokines. Our in vitro results imply that Doxo-induced alterations in BM MSC-derived interleukin 6 (IL-6), CXCL12 and growth and differentiation factor 15 (GDF-15) are not sufficient to disintegrate the support of IgG-producing ASCs by the BM MSC niche, and that serological memory loss may arise during later stages of ALL therapy.

Subject headings

NATURVETENSKAP  -- Biologi -- Immunologi (hsv//swe)
NATURAL SCIENCES  -- Biological Sciences -- Immunology (hsv//eng)
NATURVETENSKAP  -- Biologi -- Cellbiologi (hsv//swe)
NATURAL SCIENCES  -- Biological Sciences -- Cell Biology (hsv//eng)

Keyword

human bone marrow mesenchymal stromal cells
anthracycline
plasma cell niche
cytokines
chemokines
antibody-secreting cells

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

  • Hemato (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view